Article
Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome.
Human molecular genetics - 1 Apr 2009
Bian Yang, Masuda Akio, Matsuura Tohru, Ito Mikako, Okushin Kazuya, Engel Andrew G, Ohno Kinji
Abstract excerpt
We recently reported that the intronic splice-site mutation IVS3-8G>A of CHRNA1 that encodes the muscle nicotinic acetylcholine receptor alpha subunit disrupts binding of a splicing repressor, hnRNP H. This, in turn, results in exclusive inclusion of the downstream exon P3A. The P3A(+) transcript...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
